UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported): May 26, 2021 | ||
|
Blonder Tongue Laboratories, Inc. (Exact Name of registrant as specified in its charter) | ||
|
Delaware (State or other jurisdiction of incorporation) |
1-14120 (Commission File Number) |
52-1611421 (I.R.S. Employer |
|
One Jake Brown Road, Old Bridge, New Jersey 08857 (Address of principal executive offices) (Zip Code) | ||
|
Registrant’s telephone number, including area code: (732) 679-4000
| ||
|
Not Applicable (Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $.001 | BDR | NYSE American |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
The Company’s 2021 Annual Meeting of Stockholders was held on May 26, 2021. On April 15, 2021, the record date for the 2021 Annual Meeting, 11,960,505 shares of the Company’s common stock were outstanding and entitled to one vote per share upon all matters submitted at the 2021 Annual Meeting. The matters voted on at the 2021 Annual Meeting and the voting results for each matter are set forth below.
(i) Election of Directors. The following nominees were elected to serve as Class II directors of the Company, each to hold office for a three-year term to expire at the Company’s annual meeting of stockholders in 2024.
| NOMINEE | FOR | WITHHELD | BROKER NON-VOTES | |||
| John Burke | 5,617,447 | 170,352 | 2,435,900 | |||
| Robert J. Pallé | 5,649,218 | 138,581 | 2,435,900 | |||
| Gary P. Scharmett | 5,579,495 | 208,304 | 2,435,900 |
(ii) Ratification of Independent Registered Public Accounting Firm. Stockholders approved a proposal to ratify the appointment of Marcum LLP, certified public accountants, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTES | |||
| 8,013,542 | 186,723 | 23,434 | 0 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BLONDER TONGUE LABORATORIES, INC. | ||
| By: | /s/ Eric Skolnik | |
| Eric Skolnik | ||
| Senior Vice President and Chief Financial Officer | ||
Date: May 26, 2021